Clinical trial

Different Regimens of Transarterial Chemoembolization for Hepatocellular…

NCT00493402 · Sun Yat-sen University, Other · Completed

Key facts

NCT number NCT00493402
Title Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma
Official title The Efficacy, Safety, and Patient Reported Outcomes of Different Regimens of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
Acronym TACEforHCC
Lead sponsor Sun Yat-sen University, Other
Collaborators Ministry of Health, China Guangdong Provincial People's Hospital The 458 Hospital of Chinese PLA Kaiping Central Hospital
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hepatocellular Carcinoma
Intervention type Procedure
Interventions Transarterial chemoembolization (TACE)
Enrollment 365
Start date Jul 1, 2007
Primary completion Dec 1, 2010
Completion Dec 1, 2010
First posted Jun 28, 2007
Last update posted Dec 17, 2012
Countries China

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies